SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

ACADIA Pharmaceuticals Is Maintained at Market Outperform by Citizens

Ratings actions from Benzinga: GMT) ACADIA Pharmaceuticals Price Target Cut to $33.00/Share From $36.00 by CitizensRatings actions from Benzinga

ACAD

Related stories